The recommended cash offer to Abliva shareholders is now unconditional, with an extended acceptance period....
Enhancing patient-centric care with advanced digital tools and analytics. ...
The world’s longest-lasting continuous glucose monitor moves closer to European market approval. ...
The collaboration aims to drive long-term brain monitoring and neurostimulation innovations into clinical applications....
Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation ...
With a strategic separation, BD is creating a pure-play MedTech leader and a focused Life Sciences and Diagnostics entity, driving enhanced investment, innovation, and market impact....
The collaboration aims to promote virtual reality solutions for enhancing senior care and well-being....
Simultaneous approval of AI solutions for diagnosing sleep disorders and digital therapeutics for insomnia...
Strategic move aims to accelerate advancements in cancer detection and drug development....
World’s first pin-less, image-less solution for precise acetabular cup positioning in anterior hip arthroplasty....
